Contributor Page
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 4084000
Fax: +1 202 4084400
901 New York Avenue, NW
Washington, DC
DC 20001-4413
United States
By Elliot Cook
Why are patents the single-most valuable asset for some companies, yet for others just a waste of money? Most often, the difference is driven by two distinct activities:
By Sanya Sukduang, Jonathan Davies, Thomas Sullivan
On January 12, 2017, the U.S. Food and Drug Administration ("FDA") released a final Guidance for Industry, Nonproprietary Naming of Biological Products...
By James Stein
The Federal Circuit has found that it may not review a PTAB determination that an IPR petition was timely-filed within 35 U.S.C. § 315(b)'s 1-year bar.
By Virginia Carron, Ashley Winkler
The Patent Trial and Appeal Board (PTAB) has discretion under 35 US.C. § 325(d) to decline institution of inter partes review when "the same or substantially the same prior art or arguments"...
By Virginia Carron, Ashley Winkler
The Patent Trial and Appeal Board (PTAB) has discretion under 35 US.C. § 325(d) to decline institution of inter partes review when "the same or substantially the same prior art or arguments"...
By Barbara Rudolph, Robert Stanley
In recent years, certain court decisions have suggested that copying is not a significant secondary consideration of non-obviousness in pharmaceutical patent infringement cases...
By Eric Raciti, Jessica Marks, Drew Christie
Medical devices—encompassing everything from contact lenses to hemodialysis machines—are fundamental components of modern medicine.
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The TTAB recently held that trademark applicants may rely on the "family of marks" doctrine to prove acquired distinctiveness for descriptive marks, but that LC Trademarks, Inc. had failed to...
By Brian Kacedon, Daniel Klodowski, John Paul
In particular, it found that harm to Finjan's licensees did not create irreparable harm to Finjan or justify Finjan's request for a preliminary injunction.
By Jonathan J. Fagan, Brian Kacedon, John Paul
Standing to sue for patent infringement requires that the plaintiff have valid legal title in the asserted patents at the time of filing suit.
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
New rules for the Trademark Trial and Appeal Board ("TTAB") go into effect on January 14, 2017, aiming to provide more efficiency and streamlining of inter partes...
By John Paul, Brian Kacedon, Stephen Kabakoff
The Supreme Court found that damages for infringing a design patent on features of a smartphone can be based on profits from the components with the infringed designs...
By Alissa Lipton, Eric Raciti
Join us as we review what has been an exciting year at the Federal Circuit and help ring in 2017 with a New Year's reception at Finnegan's Boston office on Wednesday...
By Thomas Sullivan
In United Construction Products, Inc. v. Tile Tech, Inc., No. 2016-1392 (Fed. Cir. December 15, 2016), the Federal Circuit affirmed the district court's entry of default judgment against Tile Tech.
By Shayda Shahbazi
In Sonix Technology Co., Ltd. v. Publications International, Ltd., No. 16-1449 (Fed. Cir. Jan. 5, 2017), the Federal Circuit reversed the district court's decision that the claim term...
Contributor's Topics
More...